Firm News Resources

A federal agency has made it more difficult for the public to access the rate of “never events” in hospitals nationwide. When you have a

On behalf of Daniel C. Minc Suits have been filed for injury and death from infections from difficult-to-clean medical equipment. We all get routine medical

Recent controversy over prostate-specific antigen (PSA) testing for prostate cancer has left many men confused. In May 2012, a report was released with new government guidelines regarding PSA testing. The guidelines discouraged the use of the blood test that looks for PSA in high levels as an indication of prostate cancer. This controversial statement has been challenged by many medical professional who reassert the need for this testing.

The new guidelines

In the new guidelines, the concern was that with routine PSA testing, men were being unnecessarily treated for small tumors that were not life-threatening. With treatments such as surgery to remove the tumor and radiation therapy, patients sometimes risk complications for a tumor that would have been fine if left alone. This study found that only about one out of 1,000 men would survive prostate cancer because of a PSA test discovery.

The recommendation was met immediately with opposition from many doctors and cancer survivors. They warned that skipping PSA testing might be more dangerous than having the testing done. They also felt that the new guidelines were irresponsible because there was no other testing method more effective than PSA testing for men.